摘要 |
The present invention provides a compound represented by general formula (I): or pharmaceutically acceptable salts thereof, wherein W is O, S(O)<SUB>m</SUB>, CH<SUB>2 </SUB>and the like; R<SUP>1 </SUP>is halogen, lower alkyl, halo-lower alkyl, CN and the like; R<SUP>3 </SUP>is hydrogen and the like; R<SUP>4 </SUP>is hydrogen, halogen, alkyl, halo-lower alkyl, substituted alkyl, aryl, aralkyl, alkoxy, substituted alkoxy, alkanoyl, aroyl, -CONR<SUP>7</SUP>(R<SUP>8</SUP>), -S(O)<SUB>m</SUB>R<SUP>9</SUP>, -SO<SUB>2</SUB>NR<SUP>7</SUP>(R<SUP>8</SUP>) and the like; R<SUP>5 </SUP>is hydrogen, halogen, alkyl, substituted alkyl and the like; A is -N(R<SUP>6</SUP>)CO-A<SUP>1</SUP>-COR<SUP>10 </SUP>and the like; pharmaceutical compositions containing them and their uses, which have a high affinity to human thyroid hormone receptors, in particular human thyroid hormone receptor beta.
|